Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study
暂无分享,去创建一个
J. V. van Meerbeeck | R. Gosselin | G. van Maele | K. Tournoy | A. Kelles | S. Maddens | J. V. Meerbeeck | G. V. Maele
[1] W. De Wever,et al. Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone , 2007, European Radiology.
[2] M. A. Pozo,et al. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Byung-Tae Kim,et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.
[4] R. Cerfolio,et al. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. , 2005, The Journal of thoracic and cardiovascular surgery.
[5] R. Hustinx,et al. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] R. Coleman,et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. , 2003, The Journal of thoracic and cardiovascular surgery.
[7] J. Mountz,et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. , 2003, The Annals of thoracic surgery.
[8] Henk Kramer,et al. Current Concepts in the Mediastinal Lymph Node Staging of Nonsmall Cell Lung Cancer , 2003, Annals of surgery.
[9] G. V. von Schulthess,et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.
[10] H. Groen,et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.
[11] Y. Menda,et al. A threshold method to improve standardized uptake value reproducibility , 2000, Nuclear medicine communications.
[12] V. Lowe,et al. 18F-FDG labelling of human leukocytes , 2000, Nuclear medicine communications.
[13] P. Dupont,et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P. Dupont,et al. Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] J Bogaert,et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Maurer. Impact of Chronic Obstructive Pulmonary Disease on Post-Myocardial Infarction Outcomes , 2009 .
[17] W. De Wever,et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT , 2006, European Radiology.
[18] Otto S Hoekstra,et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[19] B. Yalcin,et al. Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.
[20] Douglas C McCrory,et al. Invasive staging of non-small cell lung cancer: a review of the current evidence. , 2003, Chest.
[21] Douglas K Owens,et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. , 2003, Annals of internal medicine.
[22] V Kalff,et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.